The 20 Best Chromophobe Renal Cell Carcinoma Doctors Near Me in Massachusetts, US

Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy.

Elizabeth Henske is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Henske is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Lymphangioleiomyomatosis, Chromophobe Renal Cell Carcinoma, Birt-Hogg-Dube Syndrome, and Renal Cell Carcinoma (RCC).

Andrew Wagner is a Urologist practicing medicine in Boston, Massachusetts. Dr. Wagner is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Prostatectomy. Dr. Wagner is board certified in American Board Of Urology.

David Mcdermott is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Mcdermott is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Melanoma, Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, and Nephrectomy. Dr. Mcdermott is board certified in American Board Of Internal Medicine.

Dr. Graeme Steele is The Professor Walter Morris-Hale Distinguished Chair in Urologic Oncology at Brigham and Women’s Hospital, surgical oncologist at Dana-Farber Cancer Institute, and assistant professor of medicine at Harvard Medical School. He received his medical degree from the University of the Witwatersrand and completed his internship in general surgery at Johannesburg Hospital. He completed residencies in general surgery and urology at the University of Witwatersrand Medical School in Johannesburg, South Africa, and became head of their Department of Urology Medical School.In 1995, he moved to Boston and completed his urology residency at the Harvard Urology Residency Program and received his fellowship in urology at Brigham and Women’s Hospital. Dr. Steele is board certified in urology.The author of numerous clinical publications, Dr. Steele has conducted research studies focusing on benign prostatic hyperplasia, urodynamic evaluation, bladder cancer, urinary cancer and testicular cancer. His clinical specialties include: urinary incontinence, urodynamic studies, urologic oncology and voiding dysfunction. Dr. Steele is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Vasectomy, and Orchiectomy. Dr. Steele is board certified in Urology.

Dr. Mossanen is a graduate of the University of California, Los Angeles (UCLA) in Los Angeles, CA and received his medical degree from the David Geffen School of Medicine at UCLA. He also holds a Master of Public Health from the Harvard T.H. Chan School of Public Health in Boston, MA. Dr. Mossanen completed a residency in Urology from the University of Washington in Seattle, WA followed by a fellowship in Urologic Oncology in the Combined Harvard Urologic Oncology Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital. Dr. Mossanen has been board certified by the American Board of Urology since 2020.His research and clinical interests include: bladder cancer, kidney cancer, kidney masses/cysts, laparoscopic surgery, penile cancer, prostate cancer, robotic surgery, testicular cancer. Dr. Mossanen is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Penile Cancer, Cystectomy, and Nephrectomy. Dr. Mossanen is board certified in Urology.

Wenxin Xu is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Xu is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Prostate Cancer, and Nephrectomy. Dr. Xu is board certified in Internal Medicine and Medical Oncology.

Richard Lee is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Orchiectomy, and Gastrostomy. Dr. Lee is board certified in Medical Oncology.

Philip Saylor is an Oncologist practicing medicine in Waltham, Massachusetts. Dr. Saylor is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Liver Embolization. Dr. Saylor is board certified in Medical Oncology.

Donald Sonn is a Urologist practicing medicine in Northampton, Massachusetts. He has been practicing medicine for over 35 years. Dr. Sonn is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Reconstructive Urology Surgery. Dr. Sonn is board certified in American Board Of Urology. Dr. Sonn is currently accepting new patients.

Mohammad Mostafavi is a Urologist practicing medicine in Northampton, Massachusetts. He has been practicing medicine for over 36 years. Dr. Mostafavi is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Ochoa Syndrome, Perirenal Abscess, Ureteroscopy, and Prostatectomy. Dr. Mostafavi is board certified in American Board Of Urology. Dr. Mostafavi is currently accepting new patients.

William Swanson is a Urologist practicing medicine in Springfield, Massachusetts. He has been practicing medicine for over 31 years. Dr. Swanson is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Kidney Stones, Boils, UPJ Obstruction, Ureteroscopy, and Nephrectomy. Dr. Swanson is board certified in American Board Of Urology. Dr. Swanson is currently accepting new patients.

Adam Tyson is a Urologist practicing medicine in Springfield, Massachusetts. He has been practicing medicine for over 19 years. Dr. Tyson is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Perirenal Abscess, Boils, Kidney Stones, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Tyson is board certified in American Board Of Urology. Dr. Tyson is currently accepting new patients.

Philip Ayvazian is a Urologist practicing medicine in Worcester, Massachusetts. He has been practicing medicine for over 38 years. Dr. Ayvazian is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 44 other conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Ureteroscopy, and Reconstructive Urology Surgery.

David Einstein is an Internal Medicine specialist and an Oncologist practicing medicine in Boston, Massachusetts. Dr. Einstein is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Prostatectomy. Dr. Einstein is board certified in American Board Of Internal Medicine.

Glenn Bubley is an Internal Medicine provider practicing medicine in Boston, Massachusetts. Dr. Bubley is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Prostatectomy, and Orchiectomy. Dr. Bubley is board certified in American Board Of Internal Medicine.

Boris Gershman is a Urologist practicing medicine in Boston, Massachusetts. Dr. Gershman is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Cystectomy. Dr. Gershman is board certified in American Board Of Urology.

Dr. Mark A. Preston is a urologic surgeon at Brigham and Women’s Hospital and Associate Professor of Surgery at Harvard Medical School. Dr. Preston received his Medical Degree from the University of Ottawa in Canada, where he also completed his residency training in Urology. He completed a three-year accredited fellowship in Urologic Oncology at Massachusetts General Hospital including a Masters of Public Health from the Harvard School of Public Health with a concentration in clinical effectiveness. He is board certified in Urology.Dr. Preston’s clinical interests include urologic oncology (bladder, kidney, prostate and testicular cancer) and minimally invasive surgery. Dr. Preston’s research focuses on the epidemiology of prostate and kidney cancer risk with an emphasis on predictive biomarkers and pharmacoepidemiology. Dr. Preston is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Cystectomy, and Prostatectomy. Dr. Preston is board certified in Urology.

Michael Curran is a Urologist practicing medicine in Dedham, Massachusetts. Dr. Curran is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Urinary Tract Infection in Children, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Curran is board certified in American Board Of Urology.

Stephen Gillard is a Urologist practicing medicine in Plymouth, Massachusetts. Dr. Gillard is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 45 other conditions, according to our data. His clinical expertise encompasses Perirenal Abscess, Boils, Urinary Tract Infection in Children, Ureteroscopy, and Prostatectomy. Dr. Gillard is board certified in American Board Of Urology.